好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Encephalitis after Influenza Vaccination in the United States: A CDC/FDA Vaccine Adverse Event Reporting System Study, 1990-2018
Autoimmune Neurology
Autoimmune Neurology Posters (7:00 AM-5:00 PM)
096

Investigate the association between influenza vaccination and the risk of developing encephalitis in the United States.

Influenza vaccinations may be associated with adverse neurological events; their safety must be continually monitored.

The Vaccine Adverse Event Reporting System database from 1990-2018 was reviewed. Cases of encephalitis, encephalomyelitis, and encephalopathy were identified, rated by the Brighton criteria, and characterized by their temporal relationship with influenza vaccination. Case-centered analysis using a logistic regression model was utilized. The initial 6 weeks after vaccination were defined as the risk period for possible cause-effect between vaccination and encephalitis.

130 cases of encephalitis (mean age 36.77 years, 60.15% male) following influenza vaccination that had a known onset time and met Brighton criteria were identified. There was an unbalanced distribution of post-vaccination encephalitis cases: 124 patients (95.38%) developed encephalitis within 6 weeks, of which 105 (84.68%) developed encephalitis within 2 weeks. 4 patients (3.08%) developed encephalitis between 6-10 weeks, and 2 (1.54%) developed encephalitis after over 10 weeks post-vaccination. 59 patients (45.38%) visited the emergency room or doctor’s office, 106 (81.54%) were hospitalized, 27 (20.77%) experienced disability, and 15 (11.54%) died. The estimated annual reporting rate of encephalitis after influenza vaccination was 0.5 cases per 10 million vaccinations given, lower than the occurrence of encephalitis in the general population. Case-centered analysis found that there is an increased risk of encephalitis in the 42 days following vaccination (relative risk: 5.682, 95% confidence interval: 4.490-7.298).

This study reveals that there is a higher risk of developing encephalitis within the first 6 weeks following influenza vaccination than outside of this period. Though the incidence of encephalitis post-vaccination is not increased as compared to the general population, the unbalanced distribution of encephalitis within the 6 weeks following influenza vaccination suggests the need for careful monitoring of recently vaccinated patients for encephalitis.

Authors/Disclosures
Nour Jedidi (Carnegie Mellon University)
PRESENTER
Nour Jedidi has nothing to disclose.
Parisorn Thepmankorn (Rutgers New Jersey Medical School) Ms. Thepmankorn has received personal compensation for serving as an employee of Johnson and Johnson.
No disclosure on file
Abu Nasar No disclosure on file
Nizar Souayah, MD, FAAN (NJMS) Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.